Today we’re talking to Nick Opie, CTO of Synchron; and we discuss how Synchron is developing a brain computer interface that can help treat various neurological diseases, the Brain.io operating system that powers the interface, and how brain computer interfaces may change the world.
All of this right here, right now, on the Modern CTO Podcast!
Learn more about Nick and Synchron at https://synchron.com/
About Nick Opie:
Nicholas has designed and developed the world’s first brain computer interface that can be implanted endovascularly without invasive brain surgery. He now has the opportunity to translate his device (the Stentrode) into clinical use for the treatment of paralysis and diversify this technology to address a wide range of other neurological conditions. Synchron co-founder Nicholas Opie, PhD is a biomedical engineer with experience in neural prostheses and medical bionics. He has published more than 50 studies in peer-review journals including Nature Biotechnology and Nature Biomedical Engineering.
Associate Professor Nicholas Opie earned his undergraduate degrees in Electrical and Computer Systems Engineering (Hons) and Science at Monash University, his PhD in retinal neuroprostheses at the University of Melbourne and his MBA from Melbourne Business School. He is an NHMRC Investigator Fellow, the Head of the Vascular Bionics Laboratory, and has been awarded more than $27M in research funding. Nicholas continues to spend his free time mentoring young researchers and entrepreneurs.
Synchron is a leading implantable brain computer interface company. The stentrode is the first commercial implantable brain computer interface to receive an FDA IDE for in human clinical trials.